Skip to main content

Table 2 Clinical Grobal Impressions-Severity at baseline and the end of treatment

From: Dosage, effectiveness, and safety of sertraline treatment for posttraumatic stress disorder in a Japanese clinical setting: a retrospective study

Baseline N = 122

The end of sertraline treatment or the last observation N = 122

Normal

Borderline

Mild

Moderate

Marked

Severe

Most severe

Not assessed

13 (10.7)

19 (15.6)

40 (32.8)

40 (32.8)

4 (3.3)

5 (4.1)

1 (0.8)

0

Normal

0

0

0

0

0

0

0

0

0

Borderline

0

0

0

0

0

0

0

0

0

Mild

16 (13.1)

3 (2.5)

4 (3.3)

7 (5.7)

2 (1.6)

0

0

0

0

Moderate

68 (55.7)

6 (4.9)

11 (9.0)

26 (21.3)

25 (20.5)

0

0

0

0

Marked

17 (13.9)

2 (1.6)

1 (0.8)

4 (3.3)

8 (6.6)

2 (1.6)

0

0

0

Severe

20 (16.4)

2 (1.6)

3 (2.5)

3 (2.5)

5 (4.1)

2 (1.6)

5 (4.1)

0

0

Most severe

1 (0.8)

0

0

0

0

0

0

1 (0.8)

0

Not assessed

0

0

0

0

0

0

0

0

0

  1. Values represent the number (%) of patients
  2. Bold = patients who showed improvement in severity from baseline
  3. Normal, normal, not at all ill, Borderline borderline mentally ill, Mild mildly ill, Moderate moderately ill, Marked markedly ill, Severe severely ill, Most severe most severely ill